To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Botulinum toxin A with cast treatment for idiopathic toe-walking does not improve outcome

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
May 2013

Botulinum toxin A with cast treatment for idiopathic toe-walking does not improve outcome

Vol: 2| Issue: 4| Number:201| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Botulinum toxin a does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial

J Bone Joint Surg Am. 2013 Mar 6;95(5):400-7. doi: 10.2106/JBJS.L.00889

Contributing Authors:
P Engstrom A Bartonek K Tedroff C Orefelt Y Haglund-Akerlind EM Gutierrez-Farewik

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

OE EXCLUSIVE

Dr.Engstrom discusses the use of Botulinum toxin A with cast treatment for idiopathic toe-walking

Synopsis

52 children were randomized to examine whether the addition of botulinum toxin A prior to cast treatment was effective in managing idiopathic toe-walking. Patients were treated with either 4 weeks of below-the-knee casts alone or 4 weeks of cast treatment 1 to 2 weeks following botulinum toxin A injections into the calves. The assessment at 12 months revealed that botulinum toxin A injections with...

Join the Conversation

Please Login or Join to leave comments.